N4P

N4 Pharma (N4P)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:N4P
DataOraFonteTitoloSimboloCompagnia
29/04/202411:59RNS Regulatory NewsN4 Pharma PLC Posting of Annual Report & Notice of AGMLSE:N4PN4 Pharma Plc
26/04/202408:00RNS Non-RegulatoryN4 Pharma PLC N4 Pharma Webinar on SRI CollaborationLSE:N4PN4 Pharma Plc
25/04/202412:56Alliance NewsAlliance NewsN4 Pharma strikes partnership deal for intracellular deliveryLSE:N4PN4 Pharma Plc
25/04/202408:38RNS Regulatory NewsN4 Pharma PLC Collaboration Agreement with SRI International IncLSE:N4PN4 Pharma Plc
23/04/202414:32Alliance NewsAlliance NewsIN BRIEF: N4 Pharma loss widens but "great optimism" remainsLSE:N4PN4 Pharma Plc
23/04/202408:00RNS Regulatory NewsN4 Pharma PLC Final ResultsLSE:N4PN4 Pharma Plc
18/04/202413:14Alliance NewsAlliance NewsN4 Pharma sees potential in Nuvec delivery method for cancer treatmentLSE:N4PN4 Pharma Plc
18/04/202408:00RNS Regulatory NewsN4 Pharma PLC Oral Delivery UpdateLSE:N4PN4 Pharma Plc
04/03/202416:13RNS Regulatory NewsN4 Pharma PLC Holding(s) in CompanyLSE:N4PN4 Pharma Plc
15/02/202413:06Alliance NewsAlliance NewsIN BRIEF: N4 Pharma shares rise on "encouraging" Nuvec researchLSE:N4PN4 Pharma Plc
15/02/202408:00RNS Regulatory NewsN4 Pharma PLC in-vitro siRNA updateLSE:N4PN4 Pharma Plc
19/01/202410:26Alliance NewsAlliance NewsIN BRIEF: N4 Pharma gets India patent for medical delivery systemLSE:N4PN4 Pharma Plc
19/01/202408:00UK RegulatoryN4 Pharma PLC Patent GrantLSE:N4PN4 Pharma Plc
16/01/202414:26Alliance NewsAlliance NewsIN BRIEF: N4 Pharma touts contract to test glaucoma treatment, ECP105LSE:N4PN4 Pharma Plc
16/01/202408:00UK RegulatoryN4 Pharma PLC Nanogenics UpdateLSE:N4PN4 Pharma Plc
08/01/202410:11Alliance NewsAlliance NewsN4 Pharma hails increased efficacy of Nuvec when complexed with AAV8LSE:N4PN4 Pharma Plc
08/01/202408:00UK RegulatoryN4 Pharma PLC AAV Viral Vector UpdateLSE:N4PN4 Pharma Plc
18/12/202313:43Alliance NewsAlliance NewsN4 Pharma rises on successful results from Nuvec administrationLSE:N4PN4 Pharma Plc
07/12/202319:28Alliance NewsAlliance NewsTRADING UPDATES: N4 Pharma hails "encouraging" siRNA researchLSE:N4PN4 Pharma Plc
07/12/202308:00UK RegulatoryN4 Pharma PLC Nuvec(R) R&D and Strategy UpdateLSE:N4PN4 Pharma Plc
01/12/202315:29Alliance NewsAlliance NewsTRADING UPDATES: N4 launches investor hub; Capricorn production fallsLSE:N4PN4 Pharma Plc
30/11/202310:00RNS Non-RegulatoryN4 Pharma PLC N4 Pharma Launches New Interactive Investor HubLSE:N4PN4 Pharma Plc
31/10/202308:00UK RegulatoryN4 Pharma PLC Total Voting RightsLSE:N4PN4 Pharma Plc
09/10/202308:00RNS Non-RegulatoryN4 Pharma PLC Investor Presentation via Investor Meet CompanyLSE:N4PN4 Pharma Plc
02/10/202308:00RNS Non-RegulatoryN4 Pharma PLC Investor PresentationLSE:N4PN4 Pharma Plc
28/09/202311:20Alliance NewsAlliance NewsN4 Pharma shares fall as places shares to fund Nanogenics stake buyLSE:N4PN4 Pharma Plc
28/09/202308:00UK RegulatoryN4 Pharma PLC Acquisition of Controlling Interest in NanogenicsLSE:N4PN4 Pharma Plc
12/09/202314:43Alliance NewsAlliance NewsN4 Pharma interim loss narrows slightly as business outreach ongoingLSE:N4PN4 Pharma Plc
12/09/202308:00UK RegulatoryN4 Pharma PLC Interim ResultsLSE:N4PN4 Pharma Plc
25/07/202311:12Alliance NewsAlliance NewsN4 Pharma shares soar on further patent grant for Nuvec in USLSE:N4PN4 Pharma Plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:N4P
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network